bladder cancer
Showing NaN - NaN of 50
Lung Cancer, Bladder Cancer, Colorectal Cancer Trial in United States (Communication of Patients Lost to Follow-up to Providers)
Withdrawn
- Lung Cancer
- +4 more
- Communication of Patients Lost to Follow-up to Providers
-
Chicago, Illinois
- +4 more
Feb 22, 2018
Bladder Cancer, Breast Cancer, Colorectal Cancer Trial in Chicago (gemcitabine HCl, irinotecan HCl)
Completed
- Bladder Cancer
- +5 more
- gemcitabine hydrochloride
- irinotecan hydrochloride
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Apr 14, 2017
Bladder Cancer Trial in United States (filgrastim, cisplatin, doxorubicin HCl)
Completed
- Bladder Cancer
- filgrastim
- +3 more
-
Scottsdale, Arizona
- +284 more
Jul 12, 2016
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Canada, United States (bortezomib)
Completed
- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
-
Chicago, Illinois
- +14 more
Jul 22, 2015
Carcinoma in Situ, Bladder Cancer Trial in United States (Valrubicin, 800 mg)
Completed
- Carcinoma in Situ
- Bladder Cancer
- Valrubicin, 800 mg
-
Alabaster, Alabama
- +38 more
Jun 10, 2015
Bladder Cancer Trial in United States (Neo-Urinary Conduit)
Completed
- Bladder Cancer
- Neo-Urinary Conduit
-
Chicago, Illinois
- +5 more
Dec 9, 2014
Bladder Cancer Trial in Canada, United States (valrubicin, conventional surgery)
Unknown status
- Bladder Cancer
- valrubicin
- conventional surgery
-
Birmingham, Alabama
- +52 more
Nov 5, 2013
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter Trial in Canada, United States (oxaliplatin)
Completed
- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
-
Chicago, Illinois
- +13 more
Sep 4, 2013
Bladder Cancer, Drug/Agent Toxicity by Tissue/Organ Trial in Chicago (amifostine trihydrate, cisplatin, gemcitabine HCl)
Completed
- Bladder Cancer
- Drug/Agent Toxicity by Tissue/Organ
- amifostine trihydrate
- +3 more
-
Chicago, IllinoisUniversity of Chicago Cancer Research Center
Sep 4, 2013
Bladder Cancer, Cervical Cancer, Endometrial Cancer Trial in Chicago (paclitaxel, vinorelbine tartrate, radiation therapy)
Completed
- Bladder Cancer
- +3 more
- paclitaxel
- +2 more
-
Chicago, IllinoisUniversity of Chicago Cancer Research Center
Sep 4, 2013
Transitional Cell Carcinoma, Bladder Tumors, Kidney Tumors Trial in Worldwide (vinflunine)
Completed
- Transitional Cell Carcinoma
- +5 more
-
Beverly Hills, California
- +74 more
Feb 27, 2010
Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer Trial in Puerto Rico, South Africa,
Completed
- Bladder Cancer
- +2 more
- docetaxel
- gemcitabine hydrochloride
-
Scottsdale, Arizona
- +75 more
Jan 26, 2010